N6-methyladenosine Reader YTHDF1-induced lncRNA DLGAP1-AS2 Promotes the c-Myc Mediated Gastric Cancer Aerobic Glycolysis

Changshun Yang,Yu Zhang,Xuefei Cheng,Weihua Li
DOI: https://doi.org/10.21203/rs.3.rs-797863/v1
2021-09-20
Abstract:Abstract Background: Emerging data has demonstrated the essential function of N 6 -methyladenosine (m 6 A) modification of long non-coding RNAs (lncRNAs) in human tumorigenesis. Nevertheless, the regulation of m 6 A-lncRNA approach on gastric cancer (GC) tumorigenesis is unclear. Methods: LncRNA expression profile data was derived from GEO. M 6 A profile was screened using Methylated RNA immunoprecipitation sequencing (MeRIP-Seq). The metabolism assays were conducted using quantitative analysis of glucose, lactate, ATP and extracellular acidification rate (ECAR). The m 6 A level of specific RNA was identified using MeRIP-qPCR. The molecular interaction was detected using RIP assay. Results: In the findings, results showed that enhanced DLGAP1-AS2 expression was correlated with advanced pathological stage and poor prognosis. Functionally, DLGAP1-AS2 promoted the aerobic glycolysis and knockdown of DLGAP1-AS2 suppressed the tumor growth of GC cells. Mechanistically, m 6 A reader YTHDF1 accelerated the enrichment of DLGAP1-AS2 in GC. Moreover, DLGAP1-AS2 interacted with YTHDF1 to integrate c-Myc mRNA, thereby enhancing the stability of c-Myc mRNA through DLGAP1-AS2/m 6 A/YTHDF1/c-Myc mRNA. Conclusions: In conclusion, our work indicates a novel m 6 A-maintained lncRNA DLGAP1-AS2 in the GC aerobic glycolysis, disclosing a m 6 A-reader-dependent modality regulation.
What problem does this paper attempt to address?